Jaguar Health, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 11.51 M

Jaguar Health, Inc. Revenue is USD 11.51 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 13.50% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Jaguar Health, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 10.14 M, a -10.29% change year over year.
  • Jaguar Health, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 11.30 M, a 97.60% change year over year.
  • Jaguar Health, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 5.72 M, a -41.38% change year over year.
  • Jaguar Health, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 9.76 M.
Key Data
Date Revenue Revenue Gross Profit Operating Income